Johnson & Johnson today announced the nipocalimab Biologics License Application (BLA) received Priority Review designation from the U.S Food and Drug Administration (FDA) for the treatment ...
Nimbus Therapeutics, LLC ("Nimbus Therapeutics" or "Nimbus"), a biotechnology company that designs and develops breakthrough medicines for patients through its powerful computational drug discovery ...
A £200million off-road busway that will plough through Cambridge’s green belt and the historic Coton Orchard is facing a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback